Methscopolamine / pseudoephedrine Pregnancy and Breastfeeding Warnings
Brand names: AlleRx Dose Pack (AM Dose), Allerx-D, Amdry-D, Extendryl PSE, Respivent-D, Sudatrate
Methscopolamine / pseudoephedrine Pregnancy Warnings
Methscopolamine-pseudoephedrine has been assigned to pregnancy category C by the FDA. There are no controlled data in human pregnancy. Methscopolamine-pseudoephedrine is only recommended for use during pregnancy when benefit outweighs risk.
Methscopolamine / pseudoephedrine Breastfeeding Warnings
There are no data on the excretion of methscopolamine-pseudoephedrine into human milk. The manufacturer recommends that a decision be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
References for pregnancy information
- (2002) "Product Information. PSE 120/MSC 2.5 (methscopolamine-pseudoephedrine)." Cypress Pharmaceutical Inc (a division of Currax Pharmaceuticals)
References for breastfeeding information
- (2002) "Product Information. PSE 120/MSC 2.5 (methscopolamine-pseudoephedrine)." Cypress Pharmaceutical Inc (a division of Currax Pharmaceuticals)
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.